Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection

Tuberculosis (TB) remains a major health problem worldwide, and the development of effective vaccines is urgently needed. Vaccination strategies based on heterologous prime–boost protocols using Mycobacterium bovis bacillus Calmette-Guérin (BCG) as primer and modified vaccinia virus Ankara strain ex...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Hum Vaccin Immunother
Hoofdauteurs: Zhang, Ming, Dong, Chunsheng, Xiong, Sidong
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2016
Onderwerpen:
Research Papers
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404650/
https://ncbi.nlm.nih.gov/pubmed/27960596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1261229
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items